Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC, 2015 FC 17

Drug: CIALIS® tadalafil 

The Court found that Mylan’s allegations of lack of utility, and specifically lack of sound prediction, and obviousness-type double patenting were not justified. As a result, an Order of Prohibition was granted.